The Australian Government has confirmed that the Community Pharmacy in Health Care Homes Trial Program will end on 30 June 2021 in line with the ending of the broader Health Care Homes Trial.
The Community Pharmacy in Health Care Homes Trial Program is funded by the Australian Government under the Sixth Community Pharmacy Agreement (6CPA) as part of a package of measures to support new and expanded 6CPA Community Pharmacy Programs including incorporation of medication management programs within Health Care Homes.
Health Care Homes are general practices or Aboriginal Community Controlled Health Services that provide better coordinated and more flexible care for Australians with chronic and complex health conditions. The Health Care Homes model was designed to help Australians better manage their conditions by giving them access to coordinated, integrated care, tailored to their needs.
Through the community pharmacy trial patients have benefited from patient-centred, coordinated medication management services delivered by their community pharmacy of choice in conjunction with their Health Care Home.
The Guild thanks all community pharmacies that have participated in this significant trial with the goal of improving the health outcomes of people with complex and chronic conditions in Australia.
After the trial ends on 30 June 2021, the trial outcomes will be evaluated and a final report will be published on the Australian Government Department of Health's website. Further information on the community pharmacy trial is available on the trial website.
